$3.27
+0.10 (+3.15%)
Open$3.18
Previous Close$3.17
Day High$3.35
Day Low$3.08
52W High$29.60
52W Low$1.21
Volume—
Avg Volume4.90M
Market Cap14.41M
P/E Ratio—
EPS$-7.63
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.85M | 7.13M | 6.14M |
| Net Income | -1,263,411 | -1,351,255 | -906,681 |
| Profit Margin | -18.4% | -19.0% | -14.8% |
| EBITDA | -2,085,898 | -2,131,542 | -1,625,986 |
| Free Cash Flow | -871,023 | -1,277,993 | -924,733 |
| Rev Growth | +20.2% | +21.4% | +12.5% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |